Last reviewed · How we verify
NCT04297397: PSTOTICU
Personalised Simulation Technologies for Optimising Treatment in the Intensive Care Unit
trial in Respiratory Distress Syndrome, Adult in 25 participants. Completed in 31 May 2022.
30 April 2022
Quick facts
| Lead sponsor | Guy's and St Thomas' NHS Foundation Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 20 February 2020 |
| Primary completion | 30 April 2022 |
| Estimated completion | 31 May 2022 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Respiratory Distress Syndrome, Adult — all drugs for Respiratory Distress Syndrome, Adult →
- Respiratory Insufficiency — all drugs for Respiratory Insufficiency →
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Who can join
Adults 18 to 100, any sex, with Respiratory Distress Syndrome, Adult or Respiratory Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to develop software models describing how critically ill patients respond to changes in their treatment whilst admitted to an Intensive Care Unit (ICU). We will use high performance computers to fit software models to the physiological and treatment data of patients receiving mechanical ventilation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04297397
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Distress Syndrome, Adult
Currently open trials in the same condition.
- NCT06203405 — The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Ra · NA · recruiting
- NCT04545424 — Trial of Therapeutic Hypothermia in Patients With ARDS · Phase 2 · recruiting
- NCT03368092 — Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma · Phase 3 · recruiting
- NCT03709199 — Long Term Follow up of Children Enrolled in the REDvent Study · active not recruiting
Other Guy's and St Thomas' NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07534917 — Comparing the Effects of Newer Pacemakers and Their Effects on the Heart and Valve Function in the Short-term. · not yet recruiting
- NCT07454135 — Mechanisms of Atrial Pathoelectrophysiology in HCM · not yet recruiting
- NCT07419945 — Older Kidney Patient Optimisation Pretransplant · NA · not yet recruiting
- NCT07309835 — Improving Genetic Medicine for Ethnic Minority Groups · not yet recruiting
- NCT07203872 — Inflammation-resolution Therapy in MINST of Periodontal Intrabony Defect: a Pilot Randomised Controlled Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04297397 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guy's and St Thomas' NHS Foundation Trust
- Last refreshed: 11 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04297397.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing